Servicio de Alergia, Hospital Universitario la Paz, IdiPAZ, CIBERER U754, Madrid, Spain.
Departamento de Alergología e Inmunología Clínica, Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Av. de Pío XII, 36, 31008, Pamplona, Navarra, Spain.
Am J Clin Dermatol. 2023 Jan;24(1):135-141. doi: 10.1007/s40257-022-00735-7. Epub 2022 Oct 30.
Problems in the definition and classification of angioedema, leading to difficulties in its diagnosis and treatment, have been identified; therefore, an improvement in the current classification of angioedema is required.
The aim of this study was to propose a practical classification of angioedema without wheals that helps to establish a differential diagnosis and take appropriate therapeutic decisions.
An initial proposal of classification of angioedema without wheals was agreed by a scientific committee of experts and was subsequently validated by a panel of experts by means of consensus based on the Delphi methodology. Forty-five items on the classification, diagnosis, and treatment of angioedema without wheals were proposed for the survey.
Most items (93.8%) were agreed after two rounds. All panelists agreed with the proposed classification, as well as with most of the clinical and treatment characteristics. The angioedema without wheals classification established three groups: histamine-mediated, bradykinin-mediated, and unknown mechanism angioedema. The clinical characteristics of the proposed types of angioedema were also agreed, except for the allergic histamine-mediated and unknown mechanism angioedema, which generated debate. Regarding treatments, although there was broad agreement with the proposed items, a lack of knowledge about some treatments in this pathology was observed.
The proposed classification of angioedema without wheals was accepted with a high degree of agreement; however, knowledge of available treatments needs to be increased and the definition of angioedema of unknown mechanism needs to be improved.
已经确定,血管性水肿在定义和分类方面存在问题,这导致其诊断和治疗较为困难;因此,需要对当前的血管性水肿分类进行改进。
本研究旨在提出一种实用的无风团血管性水肿分类方法,以帮助建立鉴别诊断并做出适当的治疗决策。
一个科学专家委员会最初提出了一种无风团血管性水肿分类方法,随后通过德尔菲法的共识,由专家组进行验证。该调查提出了 45 个关于无风团血管性水肿的分类、诊断和治疗的项目。
经过两轮后,大多数(93.8%)项目得到了一致同意。所有专家组成员均同意所提出的分类方法,以及大多数临床和治疗特征。无风团血管性水肿分类确定了三种类型:组胺介导型、缓激肽介导型和机制未知型血管性水肿。所提出的几种类型的血管性水肿的临床特征也得到了一致同意,除了过敏组胺介导型和机制未知型血管性水肿存在争议。关于治疗,尽管对所提出的项目有广泛的共识,但在这种病理情况下,一些治疗方法的知识仍存在不足。
所提出的无风团血管性水肿分类得到了高度一致的认可;然而,需要增加对现有治疗方法的了解,并改进机制未知的血管性水肿的定义。